These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37667220)

  • 1. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway.
    Cheng G; Wu J; Ji M; Hu W; Wu C; Jiang J
    BMC Cancer; 2023 Sep; 23(1):825. PubMed ID: 37667220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.
    Gao Y; Zhang N; Zeng Z; Wu Q; Jiang X; Li S; Sun W; Zhang J; Li Y; Li J; He F; Huang Z; Zhang J; Gong Y; Xie C
    Clin Transl Med; 2022 Apr; 12(4):e792. PubMed ID: 35415876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
    Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
    Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entanglement of Methylation Changes and cGAS-STING Signaling in Non-Small-Cell Lung Cancer.
    Hao F
    Comb Chem High Throughput Screen; 2023; 26(1):224-235. PubMed ID: 35585823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.
    Zheng Y; Zhou Z; Wei R; Xiao C; Zhang H; Fan T; Zheng B; Li C; He J
    J Transl Med; 2022 Jul; 20(1):343. PubMed ID: 35907982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
    Liu C; Ren W; Zhang Z; Guan J
    Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
    Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
    In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.
    Xie J; Sheng M; Rong S; Zhou D; Wang C; Wu W; Huang J; Sun Y; Wang Y; Chen P; Wu Y; Wang Y; Wang L; Zhou BO; Huang X; Walsh CP; Bohlander SK; Huang J; Wang X; Xu GL; Gao H; Shi Y
    Leukemia; 2023 Dec; 37(12):2457-2467. PubMed ID: 37816954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activation of cGAS-STING pathway enhances radiosensitivity of non-small cell lung cancer cells.
    Xue A; Shang Y; Jiao P; Zhang S; Zhu C; He X; Feng G; Fan S
    Thorac Cancer; 2022 May; 13(9):1361-1368. PubMed ID: 35429143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-eleven translocation 2 demethylates the
    Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W
    J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway.
    Shen D; Zeng Y; Zhang W; Li Y; Zhu J; Liu Z; Yan Z; Huang JA
    Eur J Pharmacol; 2022 May; 923():174925. PubMed ID: 35364069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
    Wang J; Pan X; Li J; Zhao J
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.